GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 87 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $256,000 | -12.9% | 18,000 | -10.0% | 0.01% | -12.5% |
| Q2 2020 | $294,000 | +70.9% | 20,000 | -52.1% | 0.01% | +14.3% |
| Q1 2020 | $172,000 | -60.3% | 41,761 | -53.6% | 0.01% | 0.0% |
| Q4 2019 | $433,000 | -20.6% | 90,000 | 0.0% | 0.01% | -36.4% |
| Q3 2019 | $545,000 | -23.7% | 90,000 | -18.2% | 0.01% | -42.1% |
| Q2 2019 | $714,000 | -22.6% | 110,000 | -15.4% | 0.02% | -17.4% |
| Q1 2019 | $922,000 | +45.4% | 130,000 | -0.4% | 0.02% | -11.5% |
| Q4 2018 | $634,000 | -33.9% | 130,526 | 0.0% | 0.03% | +4.0% |
| Q3 2018 | $959,000 | -11.6% | 130,526 | -23.2% | 0.02% | -3.8% |
| Q2 2018 | $1,085,000 | -0.3% | 170,000 | -15.0% | 0.03% | -23.5% |
| Q1 2018 | $1,088,000 | +72.7% | 200,000 | +32.5% | 0.03% | +112.5% |
| Q4 2017 | $630,000 | -29.7% | 151,000 | +62.4% | 0.02% | -51.5% |
| Q3 2017 | $896,000 | -16.8% | 93,000 | +2.2% | 0.03% | -26.7% |
| Q2 2017 | $1,077,000 | +20.1% | 91,000 | +30.0% | 0.04% | +25.0% |
| Q1 2017 | $897,000 | +4.7% | 70,000 | 0.0% | 0.04% | -14.3% |
| Q4 2016 | $857,000 | +5.3% | 70,000 | +1.4% | 0.04% | -16.0% |
| Q3 2016 | $814,000 | +28.4% | 69,000 | -5.3% | 0.05% | +2.0% |
| Q2 2016 | $634,000 | -3.8% | 72,900 | -41.7% | 0.05% | +69.0% |
| Q1 2016 | $659,000 | -15.1% | 125,000 | +25.0% | 0.03% | -45.3% |
| Q4 2015 | $776,000 | +38.8% | 100,000 | +40.8% | 0.05% | +112.0% |
| Q3 2015 | $559,000 | -11.8% | 71,000 | +1.4% | 0.02% | 0.0% |
| Q2 2015 | $634,000 | -29.7% | 70,000 | +0.7% | 0.02% | -37.5% |
| Q1 2015 | $902,000 | -11.7% | 69,500 | -7.3% | 0.04% | +14.3% |
| Q4 2014 | $1,021,000 | +19.8% | 75,000 | -21.1% | 0.04% | +66.7% |
| Q3 2014 | $852,000 | -37.0% | 95,000 | -5.0% | 0.02% | -27.6% |
| Q2 2014 | $1,353,000 | +18.4% | 100,000 | -13.0% | 0.03% | +26.1% |
| Q1 2014 | $1,143,000 | -31.2% | 115,000 | -8.0% | 0.02% | -36.1% |
| Q4 2013 | $1,661,000 | -24.0% | 125,000 | -30.6% | 0.04% | +50.0% |
| Q3 2013 | $2,186,000 | +651.2% | 180,000 | +540.6% | 0.02% | +200.0% |
| Q2 2013 | $291,000 | – | 28,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
| Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
| Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
| Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
| Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
| Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
| WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |